(Prof. Dennis Lo and Danny Yeung at Signing Ceremony)- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. By the year 2030, the demand for early detection cancer screenings could potentially translate into 30 million tests in Asia, annually. From prevention (CircleDNA) and early detection (Insighta) to treatment (ACT), our innovative approach promises to significantly raise the bar in healthcare.”Webcast and Transaction Presentation DetailsProf. About InsightaInsighta, a landmark Joint Venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Insighta, our US$200 million joint venture with renowned scientist Prof. Dennis Lo, underscores our unwavering commitment to saving lives through pioneering multi-cancer early detection technologies.

Source: New York Times June 26, 2023 00:58 UTC